PRESS RELEASES
chart Stem Cell Therapeutics Corp. Announces Early Exercise Warrant Incentive Program 2 Jul'09 16:59h EST  full story

Stem Cell Therapeutics Corp. is a biotechnology company focused on the development and commercialization of therapeutics that control adult stem cells in the body.

SSS   Stem Cell Therapeutics Corp. Announces Early Exercise Warrant Incentive ... 2 Jul'09 17:01h EST
AGO   Alegro Announces Stock Options Granted to Directors 2 Jul'09 15:00h EST
TLN   Notice of Thallion Pharmaceuticals 2009 Second Quarter Conference Call ... 2 Jul'09 13:27h EST
COT   Intravenous COTI-2 in Combination with Doxil(R) (Doxorubicin HCl) is More ... 2 Jul'09 09:29h EST
TKM   Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial 2 Jul'09 07:30h EST
More Press Releases...    

LARGE CAP MOVERS(over $100 mil market cap)
Volume Leaders
Nuvo Research Inc. TSX: NRI $0.34     0.00   0.00%   1,230,467
MDS Inc. TSX: MDS $6.09     -0.02   -0.33%   658,351
Biovail Corporation TSX: BVF $15.51     -0.11   -0.70%   516,835
Percent Gainers
Transition Therapeut TSX: TTH $5.33     +0.92   +20.86%   6,866
Labopharm Inc. TSX: DDS $2.82     +0.42   +17.50%   408,026
Resverlogix Corp TSX: RVX $3.00     +0.19   +6.76%   35,002
Percent Losers
Neurocrine Bioscienc NASD: NBIX $3.12     -0.21   -6.31%   104,596
Noveko International TSXV: EKO $2.08     -0.11   -5.02%   21,361
Angiotech Pharmaceut TSX: ANP $1.92     -0.08   -4.00%   109,079
  

SMALL CAP MOVERS(under $100 mil market cap)
Volume Leaders
Stem Cell Therapeuti TSXV: SSS $0.15     -0.01   -6.45%   712,822
Aastrom Biosciences NASD: ASTM $0.42     -0.01   -1.41%   637,411
BioSyntech, Inc. TSXV: BSY $0.17     +0.03   +17.86%   589,524
Percent Gainers
Vitality Products In TSXV: VPI $0.07     +0.03   +62.50%   9,000
BioSyntech, Inc. TSXV: BSY $0.17     +0.03   +17.86%   589,524
ART Advanced Researc TSX: ARA $0.08     +0.01   +14.29%   3,000
Percent Losers
Ranaz Corporation TSXV: RNZ $0.13     -0.02   -13.33%   3,500
Lorus Therapeutics I TSX: LOR $0.07     -0.01   -12.50%   77,705
Medipattern Corporat TSXV: MKI $0.18     -0.02   -10.00%   19,700
  

STOCKS HALTED/TRADE RESUMPTION

No new entries.


STOCKS WITH ABNORMAL VOLUME
Stocks with highest % deviation from avg 3 month volume.

Company Name Symbol Avg Vol Today Deviation
Biosyntech, Inc. TSXV: BSY 138.k
590.k 4.3 X
Atrium Biotechnologies Inc. TSX: ATB 89.7k
286.k 3.2 X
Akela Pharma Inc TSX: AKL 28.7k
84.7k 2.9 X
Diagnocure Inc. TSX: CUR 52.4k
126.k 2.4 X


INDUSTRY NEWS
External LinkWord-for-word, Congress big on health, energy
19 Dec 2008 (Reuters)
External LinkNational Health declares quarterly dividend
16 Dec 2008 (AP)
External LinkFinally, a summit about minorities' health dispari ...
16 Dec 2008 (USA Today)
External LinkDaschle, choice for HHS, also to oversee health reform ...
11 Dec 2008 (USA Today)
External LinkObama Says Economic Downturn Has Further Strained ...
11 Dec 2008 (CQPolitics.com Yahoo! News)
External LinkDaschle to oversee Obama's health care reform
11 Dec 2008 (AP Yahoo! News)
External LinkObama Expected To Name Daschle To Health Post
11 Dec 2008 (NPR)
External LinkClose to $51 Million In Health Grants Given
11 Dec 2008 (Washington Post)
More Headlines...    

COMPANY SHOWCASE
Company Last Chg %Chg Vol  
Beijing Marvel Cleansing Supplies 0.03  0 0.00 0 Profile

chartBeijing Marvel Cleansing Supplies

Beijing Marvel is a leading wet wipes manufacturer in China that produces a variety of non-woven wipe products for personal and household applications.


52 WEEK HIGHS & LOWS
New Highs   Last %Chg
Labopharm Inc TSX 2.82 +17.5%
Westaim Corp TSX 0.34 +9.8%
New Lows   Last %Chg
The Medipattern Corp. TSXV 0.18 -10.00%

STOCKS WITH ABNORMAL VOLUME
Stocks with highest % deviation from avg 3 month volume.

Company Name Symbol Avg Vol Today Deviation
Biosyntech, Inc. TSXV: BSY 138.k
590.k 4.3 X
Atrium Biotechnologies Inc. TSX: ATB 89.7k
286.k 3.2 X
Akela Pharma Inc TSX: AKL 28.7k
84.7k 2.9 X
Diagnocure Inc. TSX: CUR 52.4k
126.k 2.4 X
Paladin Labs Inc. TSX: PLB 63.2k
135.k 2.1 X
Westaim Corp TSX: WED 205.k
409.k 2.0 X
Helix Biopharma Corp. TSX: HBP 26.3k
52.0k 2.0 X